Jiuhe leverages state-of-the-art biotechnological manufacturing infrastructure to produce premium diagnostic solutions tailored for modern healthcare institutions worldwide. Our flagship influenza rapid test kit embodies precision engineering, utilizing high-purity monoclonal antibodies designed to target conserved viral nucleoprotein antigens with exceptional affinity. Operating within a strictly regulated ISO 13485 certified facility, every production batch undergoes rigorous multi-stage quality control inspections to ensure absolute batch-to-batch consistency and regulatory compliance. Industry benchmark data highlights that our diagnostic reagents maintain optimal reactivity even after prolonged storage, supporting international distributors and clinical procurement teams efficiently. By combining advanced lateral flow architecture with scalable manufacturing capabilities, Jiuhe remains a trusted global partner committed to empowering medical professionals with fast, dependable, and cost-effective respiratory infection screening tools.